Details for Patent: 8,877,792
✉ Email this page to a colleague
Which drugs does patent 8,877,792 protect, and when does it expire?
Patent 8,877,792 protects NUVESSA and is included in one NDA.
This patent has two patent family members in two countries.
Summary for Patent: 8,877,792
| Title: | Compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
| Abstract: | The combination of any two of a polyol, a polyol ether, and a low carbon organic alcohol provides a synergistic effect on the solubility of azole compounds, such as metronidazole, in aqueous fluid. |
| Inventor(s): | Yang; Meidong (Richmond, CA), Chen; Haigang (Edina, MT) |
| Assignee: | Dow Pharmaceutical Sciences, Inc. (Petaluma, CA) |
| Application Number: | 13/855,034 |
|
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 8,877,792
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,877,792
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 070406 | ⤷ Sign Up | |||
| World Intellectual Property Organization (WIPO) | 2009097143 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
